184 related articles for article (PubMed ID: 2462882)
21. Enhanced cytotoxicity with interleukin-1 alpha and 5-fluorouracil in HCT116 colon cancer cells.
Geoffroy FJ; Allegra CJ; Sinha B; Grem JL
Oncol Res; 1994; 6(12):581-91. PubMed ID: 7787251
[TBL] [Abstract][Full Text] [Related]
22. Deoxyuridylate effects on thymidylate synthase-5-fluorodeoxyuridylate-folate ternary complex formation.
Spears CP; Hayes AA; Shahinian AH; Danenberg PV; Frösing R; Gustavsson BG
Biochem Pharmacol; 1989 Sep; 38(18):2985-93. PubMed ID: 2783153
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of the incorporation of 5-fluorodeoxyuridylate into DNA of HL-60 cells by metabolic modulations.
Tanaka M; Kimura K; Yoshida S
Cancer Res; 1983 Nov; 43(11):5145-50. PubMed ID: 6225512
[TBL] [Abstract][Full Text] [Related]
24. Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse leukaemia cells.
Aherne GW; Hardcastle A; Raynaud F; Jackman AL
Biochem Pharmacol; 1996 May; 51(10):1293-301. PubMed ID: 8787544
[TBL] [Abstract][Full Text] [Related]
25. Modulation of 5-fluorouracil metabolism and cytotoxicity by antimetabolite pretreatment in human colorectal adenocarcinoma HCT-8.
Benz C; Cadman E
Cancer Res; 1981 Mar; 41(3):994-9. PubMed ID: 7459888
[TBL] [Abstract][Full Text] [Related]
26. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line.
Chu E; Zinn S; Boarman D; Allegra CJ
Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502
[TBL] [Abstract][Full Text] [Related]
27. Isolation and characterization of a human ileocecal carcinoma cell line (HCT-8) subclone resistant to fluorodeoxyuridine.
Zhang ZG; Malmberg M; Yin MB; Slocum HK; Rustum YM
Biochem Pharmacol; 1993 Mar; 45(5):1157-64. PubMed ID: 8461045
[TBL] [Abstract][Full Text] [Related]
28. Relationship between 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas.
Houghton JA; Weiss KD; Williams LG; Torrance PM; Houghton PJ
Biochem Pharmacol; 1986 Apr; 35(8):1351-8. PubMed ID: 3008760
[TBL] [Abstract][Full Text] [Related]
29. Rate-limiting steps in the interactions of fluoropyrimidines and methotrexate.
Bowen D; Bailey BD; Guernsey LA
Eur J Cancer Clin Oncol; 1984 May; 20(5):651-7. PubMed ID: 6234172
[TBL] [Abstract][Full Text] [Related]
30. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ
Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718
[TBL] [Abstract][Full Text] [Related]
31. Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells.
Cabral S; Leis S; Bover L; Nembrot M; Mordoh J
Proc Natl Acad Sci U S A; 1984 May; 81(10):3200-3. PubMed ID: 6587345
[TBL] [Abstract][Full Text] [Related]
32. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
Lönn U; Lönn S; Nylen U; Winblad G
Cancer Res; 1989 Mar; 49(5):1085-9. PubMed ID: 2521812
[TBL] [Abstract][Full Text] [Related]
33. Tumor-selective metabolism of 5-fluoro-2'-deoxycytidine coadministered with tetrahydrouridine compared to 5-fluorouracil in mice bearing Lewis lung carcinoma.
Boothman DA; Briggle TV; Greer S
Cancer Res; 1987 May; 47(9):2354-62. PubMed ID: 2952263
[TBL] [Abstract][Full Text] [Related]
34. Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole.
Van Mouwerik TJ; Pangallo CA; Willson JK; Fischer PH
Biochem Pharmacol; 1987 Mar; 36(6):809-14. PubMed ID: 3566784
[TBL] [Abstract][Full Text] [Related]
35. Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.
Moran RG; Spears CP; Heidelberger C
Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1456-60. PubMed ID: 108681
[TBL] [Abstract][Full Text] [Related]
36. Biochemical mechanisms of interferon modulation of 5-fluorouracil activity in colon cancer cells.
van der Wilt CL; Smid K; Aherne GW; Noordhuis P; Peters GJ
Eur J Cancer; 1997 Mar; 33(3):471-8. PubMed ID: 9155534
[TBL] [Abstract][Full Text] [Related]
37. Dipyridamole potentiates the growth-inhibitory action of methotrexate and 5-fluorouracil in human keratinocytes in vitro.
Schwartz PM; Milstone LM
J Invest Dermatol; 1989 Oct; 93(4):523-7. PubMed ID: 2476512
[TBL] [Abstract][Full Text] [Related]
38. The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
Johnston PG; Geoffrey F; Drake J; Voeller D; Grem JL; Allegra CJ
Eur J Cancer; 1996 Nov; 32A(12):2148-54. PubMed ID: 9014759
[TBL] [Abstract][Full Text] [Related]
39. Dissociation of 5-fluorouracil-induced DNA fragmentation from either its incorporation into DNA or its cytotoxicity in murine T-lymphoma (S-49) cells.
Parker WB; Kennedy KA; Klubes P
Cancer Res; 1987 Feb; 47(4):979-82. PubMed ID: 3802103
[TBL] [Abstract][Full Text] [Related]
40. Modulation of fluorouracil cytotoxicity by interferon-alpha and -gamma.
Ismail A; Van Groeningen CJ; Hardcastle A; Ren Q; Aherne GW; Geoffroy F; Allegra CJ; Grem JL
Mol Pharmacol; 1998 Feb; 53(2):252-61. PubMed ID: 9463483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
